Luyan Pharma Co Ltd (002788) - Total Liabilities

Latest as of September 2025: CN¥9.78 Billion CNY ≈ $1.43 Billion USD

Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has total liabilities worth CN¥9.78 Billion CNY (≈ $1.43 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Luyan Pharma Co Ltd (002788) cash flow conversion to assess how effectively this company generates cash.

Luyan Pharma Co Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Luyan Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Luyan Pharma Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Luyan Pharma Co Ltd Competitors by Total Liabilities

The table below lists competitors of Luyan Pharma Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Bomesc Offshore Engineering Co
SHG:603727
China CN¥1.27 Billion
Guangdong Greenway Technology Co Ltd
SHG:688345
China CN¥1.78 Billion
IRESS LTD
F:BRF
Germany €246.29 Million
Ganesh Housing Corporation Limited
NSE:GANESHHOUC
India Rs2.82 Billion
BCI Minerals Ltd
AU:BCI
Australia AU$430.26 Million
Zhejiang MustangBattery Co.Ltd
SHG:605378
China CN¥348.10 Million
Feitian Technologies Co Ltd
SHE:300386
China CN¥136.97 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Luyan Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Luyan Pharma Co Ltd (002788) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.10 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.02 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.75 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Luyan Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Luyan Pharma Co Ltd (2011–2024)

The table below shows the annual total liabilities of Luyan Pharma Co Ltd from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥9.45 Billion
≈ $1.38 Billion
+7.15%
2023-12-31 CN¥8.82 Billion
≈ $1.29 Billion
-1.96%
2022-12-31 CN¥8.99 Billion
≈ $1.32 Billion
+21.00%
2021-12-31 CN¥7.43 Billion
≈ $1.09 Billion
+23.29%
2020-12-31 CN¥6.03 Billion
≈ $882.18 Million
+6.70%
2019-12-31 CN¥5.65 Billion
≈ $826.77 Million
+27.92%
2018-12-31 CN¥4.42 Billion
≈ $646.34 Million
+23.86%
2017-12-31 CN¥3.57 Billion
≈ $521.83 Million
+67.16%
2016-12-31 CN¥2.13 Billion
≈ $312.17 Million
-20.49%
2015-12-31 CN¥2.68 Billion
≈ $392.61 Million
+0.69%
2014-12-31 CN¥2.66 Billion
≈ $389.93 Million
+17.50%
2013-12-31 CN¥2.27 Billion
≈ $331.85 Million
+27.67%
2012-12-31 CN¥1.78 Billion
≈ $259.93 Million
+82.53%
2011-12-31 CN¥973.17 Million
≈ $142.40 Million
--

About Luyan Pharma Co Ltd

SHE:002788 China Pharmaceutical Retailers
Market Cap
$776.60 Million
CN¥5.31 Billion CNY
Market Cap Rank
#10300 Global
#2978 in China
Share Price
CN¥13.66
Change (1 day)
-0.73%
52-Week Range
CN¥7.99 - CN¥27.49
All Time High
CN¥22328.40
About

Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian… Read more